Similarly, the median and mean DFS times of GC patients with high ILF2 expression separately were 26 months and 28.243 ± 2.901 months, which were shorter than those of GC patients with low ILF2 expression (median 52 months, mean 47.087 ± 3.377 months) (p < 0.001, log-rank test, Figure 5(b)). This evidence concerns the gene ILF2 and gastric cancer.